| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 27.89B | 27.73B | 27.83B | 25.51B | 21.16B | 20.50B |
| Gross Profit | 6.57B | 6.54B | 6.48B | 5.90B | 4.96B | 4.54B |
| EBITDA | 4.55B | 4.29B | 4.60B | 3.96B | 1.33B | 1.83B |
| Net Income | 3.12B | 2.59B | 2.98B | 1.94B | -601.00M | -219.00M |
Balance Sheet | ||||||
| Total Assets | 50.90B | 40.88B | 38.36B | 36.95B | 34.18B | 35.35B |
| Cash, Cash Equivalents and Short-Term Investments | 14.76B | 4.96B | 3.36B | 2.65B | 2.49B | 3.85B |
| Total Debt | 16.16B | 7.14B | 6.02B | 6.02B | 6.66B | 6.73B |
| Total Liabilities | 31.41B | 21.87B | 21.31B | 21.43B | 19.66B | 18.56B |
| Stockholders Equity | 19.31B | 18.83B | 16.89B | 15.37B | 14.39B | 14.83B |
Cash Flow | ||||||
| Free Cash Flow | 2.29B | 2.54B | 2.05B | 1.84B | 1.12B | 1.83B |
| Operating Cash Flow | 3.60B | 3.81B | 3.33B | 3.06B | 1.89B | 2.37B |
| Investing Cash Flow | -696.00M | -2.04B | -1.02B | -817.00M | -1.56B | -463.00M |
| Financing Cash Flow | 8.54B | -1.48B | -1.53B | -2.03B | -1.59B | -2.14B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | $33.75B | 10.34 | 11.48% | 4.43% | -3.95% | 2.15% | |
79 Outperform | $67.84B | 16.25 | 16.24% | 2.04% | 0.20% | 6.96% | |
79 Outperform | $30.05B | 19.37 | 29.62% | 0.44% | 9.36% | 19.24% | |
74 Outperform | $82.91B | 25.61 | 13.30% | 2.98% | -0.49% | -22.59% | |
65 Neutral | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% | |
62 Neutral | $33.52B | 17.70 | 14.67% | 2.41% | -1.72% | -23.60% | |
59 Neutral | $7.51B | 89.35 | 2.26% | 3.24% | -1.35% | -76.59% |